Company intelligence / Profile preview

Guangzhou Hanfang Pharmaceutical

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Guangzhou Hanfang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM) and the production of high-purity pharmaceutical excipients. It is a major global supplier of pharmaceutical-grade cholesterol and lipids used in lipid nanoparticle (LNP) delivery systems for vaccines and biological drugs.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Lipid nanoparticle delivery therapySmall moleculeNatural product extractsPeptides
Industry: Biotech

Drug pipeline

3 assets

LBZ-18

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

Guangzhou Pharmaceutical Group

Beyond the preview

Go deeper on Guangzhou Hanfang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Hanfang Pharmaceutical.

Explore the full profile